Rapid growth often associated with cashflow issues
”Manufacturing costs for the PromarkerD immunoassay, successfully producing reagents tomeet supply needs for the next six months” (at what level of demand?).
We don’t want them to run out and not meet demand.
- Forums
- ASX - By Stock
- Ann: Proteomics to raise $6.5m through Institutional Placement
PIQ
proteomics international laboratories ltd
Add to My Watchlist
2.67%
!
36.5¢

Rapid growth often associated with cashflow issues”Manufacturing...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.5¢ |
Change
-0.010(2.67%) |
Mkt cap ! $59.68M |
Open | High | Low | Value | Volume |
37.5¢ | 37.5¢ | 36.0¢ | $41.74K | 113.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17814 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 95239 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 17814 | 0.365 |
9 | 99975 | 0.360 |
1 | 81739 | 0.355 |
6 | 80549 | 0.350 |
1 | 2000 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 95239 | 2 |
0.375 | 2498 | 1 |
0.380 | 20000 | 1 |
0.385 | 19500 | 1 |
0.395 | 45000 | 1 |
Last trade - 15.57pm 18/06/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online